SCHEMBL5718653

SCHEMBL5718653

C[Si](C)(C)CNc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.65
ALDH1A1 P00352 3/20 0.55
RECQL P46063 1/20 0.55
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.50
GLA P06280 1/20 0.50
PTPRF P10586 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN11 Q06124 1/20 0.49
ALOX5 P09917 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
ALOX12 P18054 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 1/20 0.47
RAB9A P51151 1/20 0.47
IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9341386 0.80 MAPT (0.58) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL5718646 0.80 ALDH1A1 (0.64) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL570831 0.79 MAPT (1.00) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL9003269 0.78 MAPT (0.70) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL4955548 0.78 MAPT (0.70) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
Bromide SCHEMBL28010281 0.77 MAPT (0.96) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
Hydrochloric Acid SCHEMBL1405413 0.77 MAPT (0.96) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL10489391 0.76 MAPT (0.72) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL11124580 0.76 MAPT (0.71) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2
SCHEMBL13519848 0.75 MAPT (0.66) MAPTALDH1A1RECQLHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1298135-B1 Dyeing composition containing silyl substituted p-aminophenol or p-phenylenediamine OREAL (FR) 2006-08-16 EP disclosed
US-7018427-B2 Dyeing composition containing a para-aminophenol or para-phenylenediamine compound substituted with a silane radical L'OREAL S.A. (FR) 2006-03-28 US disclosed
US-20030150066-A1 Dyeing composition containing a para-aminophenol or para-phenylenediamine compound substituted with a silane radical L'OREAL S.A. (FR) 2003-08-14 US disclosed
EP-1298135-A1 Dyeing composition containing silyl substituted p-aminophenol or p-phenylenediamine L'OREAL (FR) 2003-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030150066-A1 Dyeing composition containing a para-aminophenol or para-phenylenediamine compound substituted with a silane radical KRT18, CDC73, S100P MAPT 934/4885ALDH1A1 161/4885RECQL 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.